Trademark: 98062540
Status Date
Friday, November 3, 2023
Filing Date
Wednesday, June 28, 2023
Abandoned Date
Thursday, November 2, 2023
5 Pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies; Pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies by restoring mitochondrial health via pathways that regulate mitochondrial and organelle dynamics
42 Pharmaceutical research and development; Research and development of pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies; Research and development of pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies by restoring mitochondrial health via pathways that regulate mitochondrial and organelle dynamics
Nov 3, 2023
Abandonment Notice E-Mailed - Express Abandonment
Nov 2, 2023
Teas Express Abandonment Received
Nov 3, 2023
Abandonment Notice Mailed - Express Abandonment
Nov 3, 2023
Abandonment - Express Mailed
Jul 31, 2023
New Application Office Supplied Data Entered
Jul 1, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24